stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. QTRX
    stockgist
    HomeTop MoversCompaniesConcepts
    QTRX logo

    Quanterix Corporation

    QTRX
    NASDAQ
    Healthcare
    Medical - Devices
    Billerica, MA, US471 employeesquanterix.com
    $3.74
    +0.26(7.47%)

    Mkt Cap $176M

    $3.43
    $8.06

    52-Week Range

    At A Glance

    1

    Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in No...

    2

    Revenue is primarily driven by Product (25.7%) and Consumable And Other Products (21.2%).

    3

    Most recently: Results of Operations and Financial Condition. On March 2, 2026, Quanterix Corporation (“Quanterix”) issued a press release announcing its financial results for (2026-03-02).

    $176M

    Market Cap

    $139M

    Revenue

    -$108M

    Net Income

    Employees471
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Product25.7%($505M)
    Consumable And Other Products21.2%($417M)
    Service And Other Revenue13.8%($271M)
    Simoa Product Revenue11.8%($230M)
    Research Services9.4%($184M)
    Simoa Service And Other Revenue6.3%($124M)
    Instrument Products4.5%($88M)
    Service Type Warranties3.2%($63M)
    Other Services1.2%($24M)
    Spatial Product Revenue1.1%($22M)
    License And Service0.8%($15M)
    Spatial Service And Other Revenue0.6%($12M)
    Grant0.4%($7M)

    Revenue by Geography

    North America62.2%($487M)
    EMEA26.3%($206M)
    Asia Pacific11.4%($89M)
    Activity

    What Changed Recently

    Financial Results
    Mar 1, 2026

    Results of Operations and Financial Condition. On March 2, 2026, Quanterix Corporation (“Quanterix”) issued a press release announcing its financial results for

    Management Change+3 More
    Jan 7, 2026

    of this Form 8-K (including the portion of Exhibit 99.1 that discusses Quanterix’s expectations regarding certain financial results for the fiscal year ended De

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    VMDViemed Healthcare, Inc.$9.63+0.47%$372M23.4
    SENSSenseonics Holdings, Inc.$6.88+3.46%$287M-3.9
    MASS908 Devices Inc.$6.64+6.92%$248M11.4
    CVRXCVRx, Inc.$9.05-0.55%$238M-4.1
    IMRXImmuneering Corporation$5.45+2.25%$198M-4.0
    SGHTSight Sciences, Inc.$3.51-4.10%$190M-5.0
    INGNInogen, Inc.$6.20-1.12%$169M-7.7
    NNOXNano-X Imaging Ltd.$2.42+0.62%$155M-2.8
    Analyst View
    Company Profile
    CIK0001503274
    ISINUS74766Q1013
    CUSIP74766Q101
    Phone617 301 9400
    AddressBuilding 1, Billerica, MA, 01821, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice